DUA_DREXEL UNIV_EPI (00).PDF

Maricopa County — Formal (2021-03-24)

View PDF Item 45 Meeting page

Extracted text (via pymupdf_layout) 18833 characters
Data Use And Non-Disclosure Agreement
Between
Maricopa County Department of Public Health
And
Drexel University Urban Health Collaborative
This DATA USE AND NON-DISCLOSURE AGREEMENT (“Agreement”) made as of
March 24, 2021 (“Effective Date”) by and between Maricopa County, having its primary offices
at 301 W Jefferson Street, , Phoenix, Arizona, 85003, acting through its Department of Public
Health (“MCDPH”) and Drexel University for its Urban Health Collaborative (“Data
Recipient”), having its primary office at 3600 Market Street, 7th Floor, Philadelphia,
Pennsylvania, 19104, (each a “Party” and, collectively, the “Parties”).
WHEREAS, the MCDPH is authorized to share the Data, as defined herein, with the Data
Recipient;
WHEREAS, the Data Recipient desires to use the Data for public, educational or research
purposes that have been approved by MCDPH including (1) conduct of research with intent to
publish and (2) creation of a public dashboard as part of a partnership with the Big Cities Health
Coalition (“BCHC”) of which Maricopa County is a member; and
NOW, THEREFORE, in consideration of the mutual promises and covenants contained in this
Agreement, and other valuable and good consideration, the receipt and sufficiency of which are
hereby acknowledged, the Parties agree to the following:
I. TERM AND TERMINATION
A. Term. This Agreement shall commence as of the Effective Date and shall
terminate five (5) years from the Effective Date unless terminated earlier pursuant to
this Section I.
B. Termination for Cause. Breach of a material provision of this Agreement by the
Data Recipient, or the Authorized Users (as designated pursuant to Section V(B)(1)),
shall be grounds for termination of this Agreement for cause by MCDPH. Upon
becoming aware of such a breach of a material provision, MCDPH may do one or
more of the following:
1. Provide an opportunity for Data Recipient to cure the breach or end the
violation within four (4) days or such greater time period specified by
MCDPH, and terminate the Agreement if Data Recipient does not cure the
breach or end the violation within four (4) days or such other time period
specified by MCDPH;
Page 1

2. Demand assurances from the Data Recipient that remedial actions will be
taken to remedy the circumstances that gave rise to the breach or violation
within a time frame set by, or approved by, MCDPH;
3. Immediately terminate the Agreement; and/or
4. Determine that no further Data (as defined in Section III(A)) or other
information will be released to Data Recipient for a period of time to be
determined by MCDPH.
C. Termination by MCDPH without Cause. MCDPH may terminate this Agreement
at any time by providing fifteen (15) days written notice to Data Recipient.
D. Effect of Termination and Expiration.
1. The Data Recipient will not be entitled to any damages by reason of the
termination of this Agreement.
2. Upon the expiration or termination of this Agreement for any reason, the
confidentiality provisions set forth herein shall continue to apply to the Data
shared with Data Recipient pursuant to this Agreement. Except as provided in
paragraph (3) of this subsection D, upon expiration or termination of this
Agreement for any reason, Data Recipient shall return or destroy the Data
provided by MCDPH that Data Recipient maintains in any form, and all
copies of the Data in all its forms. If such Data is destroyed pursuant to the
foregoing sentence, Data Recipient must confirm in writing to MCDPH or
using such other form approved by MCDPH, Data Recipient’s destruction of
the Data, and all copies thereof, within sixty (60) days of the expiration or
termination of this Agreement.
3. Data incorporated into the public dashboard described in Attachment B,
paragraph B shall remain posted and in the public domain.
II. PURPOSE OF AGREEMENT
This Agreement sets forth the terms and conditions under which MCDPH will permit
Data Recipient access to and use of Data, as defined in Section III(A) of this
Agreement. This Agreement also describes in Attachment B what use the Data
Recipient may make of the Data. Furthermore, this Agreement also sets forth the
security requirements that such access and use is conditioned upon, including the
Updated January 2021 Page 2

responsibilities the Data Recipient agrees to assume in connection with such access
and use of the Data, and all permutations of the Data, and the procedures for security,
transfer, use, retention, ownership, and confidentiality of the Data.
III. THE DATA
A. Definition of Data. “Data” shall mean the data produced by MCDPH and
transmitted to Data Recipient as set forth in Attachment A to this Agreement. Under
no circumstances shall MCDPH provide the Data Recipient with any information or
data that does not qualify as part of a “limited data set” as defined under 45 C.F.R.
§164.514(e).
B. Data Transmission. Upon the execution of this Agreement by the Parties, MCDPH
shall securely transmit Data to the Data Recipient by means of an encrypted HIPAA-
compliant file submission system (e.g., LiquidFiles).
C. Data Ownership. The Data Recipient hereby acknowledges that MCDPH retains
sole ownership of the Data and all intellectual property rights therein. No license or
conveyance of any such rights in the Data is granted or implied under this Agreement.
Data Recipient shall not make, cause to be made, use or sell for any purpose any
product or other item using, incorporating or derived from the Data, other than for the
purpose stated in Attachment B for which the Data was provided under this
Agreement.
D. Cost and Expenses. Each Party will bear its own costs and expenses in performing
its duties and obligations under this Agreement.
IV. PERMITTED USES OF THE DATA AND IRB APPROVAL
A. Data Recipient agrees to use the Data solely for the purposes set forth in Attachment
B to this Agreement, and for no other purposes.
B. Where Data Recipient has been provided Data pursuant to this Agreement and the
Data do not contain any identifying information, Data Recipient shall not use the
Data, either alone or in conjunction with any other information, in any effort to
identify or locate any person to whom the Data relates.
C. Institutional Review Board (IRB) Review. This project is for both surveillance
purposes and research purposes. Research use of the data is under the purview of the
Updated January 2021 Page 3

IRB. The Drexel Urban Health Collaborative will acquire IRB approval from the
Drexel University Internal Review Board before engaging in any research with the
shared data. Surveillance activities may move forward without IRB approval as they
are considered “Public Health: Non-Research” and not under the purview of the IRB.
V. CONFIDENTIALITY AND SECURITY OF DATA
A. Compliance with Applicable Privacy and Security Laws, Rules, and Regulations.
The Data provided under this Agreement shall be used and maintained in accordance
with applicable provisions of federal, state, and local laws, rules and regulations.
B. Restrict Access to “Authorized Users”.
1. Access to the Data will be restricted to Data Recipient and Data Recipient’s
research team, employees, agents and/or contractors required to use the Data
to perform the functions of this Agreement that are set forth in Attachment B,
and so designated by Data Recipient as “Authorized Users” in Attachment C
to this Agreement.
2. Such Authorized Users must be notified and trained by Data Recipient as to
the confidential nature of the Data and its proper handling.
3. Data Recipient certifies that all Authorized Users will be subject to the
obligations of confidentiality and non-disclosure no less stringent than those
contained in this Agreement.
4. Data Recipient shall immediately notify MCDPH of any changes to the list of
Authorized Users.
5. Data Recipient shall immediately notify MCDPH if any Authorized User has
failed to comply with the terms of this Agreement and/or has compromised
the privacy and security of the Data. Such conduct may result in the
immediate removal of the user from the list of Authorized Users and the
immediate termination of Data access to that specific user.
C. Security and Confidentiality. When Data Recipient receives Data from MCDPH in
accordance with this Agreement, or creates and/or uses files derived from Data, Data
Recipient shall maintain the security and confidentiality of Data as required by this
Agreement and applicable laws, rules and regulations. Except as otherwise provided
Updated January 2021 Page 4

in this Agreement, Data Recipient shall not, at any time, directly or indirectly,
disclose, share, give, loan, sell, or otherwise grant access to the Data provided
pursuant to this Agreement, in part or in whole, to any other person or organization.
For purposes of this Agreement, the terms “disclose,” “disclosed” and “disclosure” in
relation to Data shall have their ordinary meaning but shall be deemed to include
providing access to, gaining access to, or being able to view, Data.
1. Disclosure of Individually Identifiable Information. Data Recipient shall
not disclose Data, or any information it receives pursuant to this
Agreement, that is individually identifiable information, or information,
which combined with publicly available information, may reasonably be
used to identify an individual.
2. Reporting Unauthorized or Inadvertent Use or Disclosure.
Data Recipient agrees to report to MCDPH in writing (i) if Data Recipient
reasonably suspects the occurrence of (a) any unauthorized or inadvertent use
or disclosure of the Data by Data Recipient, Data Recipient’s research team,
employees, agents and/or contractors in violation of this Agreement,
including, but not limited to, the theft or loss of portable devices or equipment
containing Data or copies of Data, and/or (b) any unauthorized or inadvertent
use or disclosure of the Data resulting from hacking, software, malware,
ransomware, computer code, algorithm or other means (each of item (a) and
(b), an “unauthorized or inadvertent use or disclosure”), and (ii) any remedial
action to be taken by Data Recipient with respect to such suspected
occurrence of an unauthorized or inadvertent use or disclosure. Data
Recipient shall make such report to the designated privacy officer of MCDPH
in writing, immediately after Data Recipient becomes aware of such suspected
occurrence of the unauthorized or inadvertent use or disclosure. Data
Recipient agrees to fully cooperate with any investigation conducted by the
County or its agents to determine whether an unauthorized or inadvertent use
or disclosure has occurred and the nature and extent of such unauthorized or
inadvertent use or disclosure.
3. Accounting for Unauthorized or Inadvertent Use or Disclosure. In the event
of an unauthorized or inadvertent use or disclosure, Data Recipient shall
ensure that a proper record of such unauthorized or inadvertent use or
disclosure is kept and immediately provided to MCDPH. Data Recipient shall
also assist in any subsequent investigation of the unauthorized or inadvertent
use or disclosure and mitigate any possible resulting damages of same.
D. Safeguards to Protect the Data. Data Recipient shall take all reasonable measures
to safeguard and keep the Data confidential and secure.
Updated January 2021 Page 5

VI. PUBLICATION AND PUBLIC RELEASE OF DATA
A. Data Recipient shall not reveal any individually identifiable information received
pursuant to this Agreement, such as a person’s first or last name, date of birth, or any
other identifying information, in any draft or final publication.
B. Subject to the terms of this Agreement, including without limitation, Section XI(A)
and Attachment B, Data Recipient may publish or publicly present its work as
described in Attachment B consistent with the project purposes and permitted uses
described therein.
VII. MERGER CLAUSE
This Agreement and the Attachments hereto constitute the entire understanding of the
Parties and merges all prior discussions, agreements or understandings into it. No
prior agreement, oral or otherwise, regarding the subject matter of this Agreement
shall be deemed to exist or to bind any of the Parties.
VIII. MODIFICATION
A. This Agreement may, from time to time, be modified by a writing signed by
authorized representatives of the Parties. It may not be altered, modified, rescinded
or extended orally.
B. The Attachments hereto may be modified upon written agreement by the Parties
without the need to formally amend this Agreement. Each attachment that is
modified shall be deemed to be part of this Agreement and will supersede any prior
Attachment, or Attachment modification, as applicable. Upon the modification of
any Attachment, all references in this Agreement to such attachment shall be deemed
to be references to the Attachment as modified.
IX. COUNTERPARTS; FACSIMILE AND ELECTRONIC SIGNATURES.
Provided that all Parties execute a copy of this Agreement, this Agreement may be
executed in counterparts, each of which shall constitute an original, and all of which
together shall constitute one and the same document. This Agreement may be
executed by the Parties and transmitted by facsimile or electronic transmission, and, if
so executed and transmitted, shall be effective as if the Parties had delivered an
executed original of this Agreement.
Updated January 2021 Page 6

IN WITNESS WHEREOF, and intending to be legally bound, the Parties hereto have executed
this Agreement as of the day and date first written above.
MARICOPA COUNTY, acting through its DEPARTMENT OF PUBLIC HEALTH:
By: ____________________________________
Name: Jack Sellers
Title: Chairman, Board of Supervisors
Date: _____________
APPROVED AS TO FORM:
_________________________________________________
Attorney for County Date
ATTEST:
_________________________________________________
Office of the Clerk of the Board Date
DREXEL UNIVERSITY, for its URBAN HEALTH COLLABORATIVE:
By: ________________________________________
Name: ______________________________________
Title: _______________________________________
Date: _______________
Updated January 2021 Page 7

Data Use And Non-Disclosure Agreement
ATTACHMENT A – DATA POINTS
In accordance with Section III(A) of this Agreement, Data shall mean the data produced by MCDPH and
transmitted to Data Recipient pursuant to this Agreement and will include the specific description and
data elements set forth below:
The Drexel Urban Health Collaborative requests receipt of anonymous individual-level data separately for
COVID-19 tests, confirmed cases, hospitalizations and deaths, to be received on a regular periodic basis.
Individual level data includes one row per test or case or hospitalization or death with associated
variables.
• Tests: date of test collection, test result (positive/negative/pending), age, sex, race/ethnicity, zip
code of residence (or census tract), congregate setting information (categorized as available)
• Cases: date of positive test, date of symptom onset, age, sex, race/ethnicity, zip code of residence
(or census tract), congregate setting information (categorized as available)
• Hospitalizations of confirmed cases: date of hospitalization, date of discharge, ICU (yes/no), age,
sex, race/ethnicity, zip code of residence (or census tract), congregate setting (categorized as
available)
• Deaths: date of death, age, sex, race/ethnicity, zip code of residence (or census tract), congregate
setting (categorized as available)
If possible, the dataset files could be integrated so that tests (and confirmed cases), hospitalizations and
deaths can be linked to each other via a common anonymized identifier.
Additionally, we request syndromic disease surveillance data, cross classified by age, sex, race/ethnicity,
zip code (or tract).
Updated January 2021 Page 8

Data Use and Non-Disclosure Agreement
ATTACHMENT B – Project Description and Data Use
In accordance with Section IV(A) of this Agreement, Data Recipient agrees to use the Data
solely for the purposes and project set forth below, and for no other purposes:
The project consists of two parts:
A. Research component: Analyses of individual-level data (linked to zip code or census
tract data if appropriate) to:
a. characterize inequities in COVID-19 testing, cases, hospitalization, mortality or
other aspects and their evolution over time.
b. examine the impact of various city or neighborhood factors on rates of COVID
related outcomes or changes in outcomes over time.
These analyses are expected to result in scientific presentations and publications.
MCDPH researchers and staff will be included as co-authors in these publications if desired and
in accordance with guidelines regarding co authorship in publications.
B. Surveillance and tracking component. Collaborate with the Big Cities Health Coalition
in the creation of a data visualization platform and dashboard that compares the evolution
of COVID-19 related outcomes and inequities in COVID-19 related outcomes in the
member cities over time. The goals of this component are:
1. Create a data platform with visualizations and web interface that allows for timely
comparisons of key COVID-19 indicators across BCHC cities over time.
2. Describe inequities in key COVID -19 indicators in BCHC cities and compare
inequities across cities and over time.
The summary statistics published on the platform will include rates of various COVID-19
related outcomes in each city and over time for the city as a whole as well as stratified by
race /ethnicity, gender and age groups. It will also include rates by neighborhood over time
stratified by race/ethnicity, gender and age, if sample size permits. The dashboard will have
public access and will allow download of summary statistics (such as rates) displayed for
each city. Only aggregate data for each city or for census tracts or zip codes within cities will
be displayed.
Updated January 2021 Page 9

Data Use And Non-Disclosure Agreement
ATTACHMENT C – AUTHORIZED USERS
In accordance with Section V(B) of this Agreement, Data Recipient agrees that access to the
Data will be restricted to the Authorized Users listed below. These Authorized Users are Data
Recipient, and Data Recipient’s research team, employees, agents and/or contractors who will
require access to the Data to further the purposes and uses set forth in Attachment B.
Role Name
Principal Investigator Ana V. Diez Roux
Principal Investigator Jennifer Kolker
Co-Investigator Usama Bilal
Co-Investigator Sharrelle Barber
Data Analyst Ran Li
Data Analyst Heather Rollins
Data Analyst (RA) Kristina Dureja
Research Coordinator Edwin McCulley
Post-doctoral fellow Alina Schnake-Mahl
Post-doctoral fellow Pricila Mullachery
Geographic Information Steve Melly
System (GIS) Specialist
Research and Data Director Kari Moore
Updated January 2021 Page 10